Sign in
ATYR Stock Price, Chart, Stats & News
aTyr Pharma, Inc.
Save
aTyr Pharma, Inc. (ATYR) does not currently pay a dividend.
29.91M
Market cap
–
Current P/E
–
Forward P/E
ATYR chart
Fundamentals
Gross margin | -11754.74% |
Operating margin | -40856.32% |
Pretax margin | -39012.11% |
Net margin | -39009.47% |
Effective tax rate | – |
ROA | -78.71% |
ROE | -99.62% |
D/E | 0.18x |
Interest coverage ratio | – |
ATYR valuation
P/E | – |
P/S | 388.08x |
P/B | 1.09x |
P/CF | -1.19x |
P/FCF | -1.19x |
P/OCF | -1.19x |
PEG | -0.21x |
EV multiple | -0.96x |
About
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2.
Similar securities
Based on sector and market capitalization
Report issue